BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cui HF, Jiang XL. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol 1999; 5(5): 448-450 [PMID: 11819488 DOI: 10.3748/wjg.v5.i5.448]
URL: https://www.wjgnet.com/1007-9327/full/v5/i5/448.htm
Number Citing Articles
Liwen Hong, Gaoxian Chen, Zhengwei Cai, Hua Liu, Chen Zhang, Fei Wang, Zeyu Xiao, Jie Zhong, Lei Wang, Zhengting Wang, Wenguo Cui. Balancing Microthrombosis and Inflammation via Injectable Protein Hydrogel for Inflammatory Bowel DiseaseAdvanced Science 2022; 9(20) doi: 10.1002/advs.202200281
Valter Alvarenga, Rodrigo Goulart Pacheco, Christiano Costa Esposito, Fernanda Buongusto, Morgana Teixeira Lima Castelo-Branco, Kalil Madi, Celso R. Belmiro, Mauro Sergio Gonçalves Pavão, Heitor Siffert Pereira de Souza, Alberto Schanaider. Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitisSurgery 2014; 155(2): 217 doi: 10.1016/j.surg.2013.06.057
Jun-Yong Luo, Yan Zhong, Ji-Chao Cao, Hui-Fei Cui. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitisBiomedicine & Pharmacotherapy 2011; 65(2): 111 doi: 10.1016/j.biopha.2010.12.013
Sheng-Li Ji, Hui-Fei Cui, Feng Shi, Yan-Qing Chi, Ji-Chao Cao, Mei-Yu Geng, Hua-Shi Guan. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytesWorld Journal of Gastroenterology 2004; 10(23): 3490-3494 doi: 10.3748/wjg.v10.i23.3490
Li Liu, Zhi-Peng Wang, Chang-Tai Xu, Bo-Rong Pan, Qi-Bing Mei, Yin Long, Jia-Yun Liu, Si-Yuan Zhou. Effects of <italic>Rheum tanguticum</italic> polysaccharide on TNBS -induced colitis and CD4<sup>+</sup> T cells in ratsWorld Journal of Gastroenterology 2003; 9(10): 2284-2288 doi: 10.3748/wjg.v9.i10.2284
Timothy J. Poterucha, Peter Libby, Samuel Z. Goldhaber. More than an anticoagulant: Do heparins have direct anti-inflammatory effects?Thrombosis and Haemostasis 2017; 117(03): 437 doi: 10.1160/TH16-08-0620
Nilesh Chande, John WD McDonald, John K MacDonald, Nilesh Chande. Cochrane Database of Systematic Reviews2008;  doi: 10.1002/14651858.CD006774.pub2
Xue-Liang Jiang, Hui-Fei Cui. An analysis of 10218 ulcerative colitis cases in ChinaWorld Journal of Gastroenterology 2002; 8(1): 158-161 doi: 10.3748/wjg.v8.i1.158
Xue-Liang Jiang, Hui-Fei Cui. Different therapy for different types of ulcerative colitis in ChinaWorld Journal of Gastroenterology 2004; 10(10): 1513-1520 doi: 10.3748/wjg.v10.i10.1513
L. PASTORELLI, S. SAIBENI, L. SPINA, C. SIGNORELLI, G. CELASCO, R. DE FRANCHIS, M. VECCHI. Oral, colonic‐release low‐molecular‐weight heparin: an initial open study of Parnaparin‐MMX for the treatment of mild‐to‐moderate left‐sided ulcerative colitisAlimentary Pharmacology & Therapeutics 2008; 28(5): 581 doi: 10.1111/j.1365-2036.2008.03757.x
Nusrat A. Motlekar, Bi-Botti C. Youan. The quest for non-invasive delivery of bioactive macromolecules: A focus on heparinsJournal of Controlled Release 2006; 113(2): 91 doi: 10.1016/j.jconrel.2006.04.008
G. CELASCO, A. PAPA, R. JONES, L. MORO, R. BOZZELLA, M. M. SURACE, G. C. NACCARI, G. GASBARRINI. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX®) for active left‐sided ulcerative colitisAlimentary Pharmacology & Therapeutics 2010; 31(3): 375 doi: 10.1111/j.1365-2036.2009.04194.x
J. SHEN, Z. H. RAN, J. L. TONG, S. D. XIAO. Meta‐analysis: the utility and safety of heparin in the treatment of active ulcerative colitisAlimentary Pharmacology & Therapeutics 2007; 26(5): 653 doi: 10.1111/j.1365-2036.2007.03418.x
Justin C Chang, Russell D Cohen. Medical management of severe ulcerative colitisGastroenterology Clinics of North America 2004; 33(2): 235 doi: 10.1016/j.gtc.2004.02.005
Giuseppe Celasco, Luigi Moro, Roberta Bozzella, Katia Mangano, Cinzia Quattrocchi, Caterina Aiello, Marco Donia, Paolo Fagone, Roberto Di Marco. Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in RatDigestive Diseases and Sciences 2008; 53(12): 3170 doi: 10.1007/s10620-008-0299-6
Nilesh Chande, Yongjun Wang, John WD McDonald, John K MacDonald. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisCochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD006774.pub4
Wei-Guo Dong, Shao-Ping Liu, Hai-Hang Zhu, He-Sheng Luo, Jie-Ping Yu. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitisWorld Journal of Gastroenterology 2004; 10(4): 606-609 doi: 10.3748/wjg.v10.i4.606
Hu Zhang, Qin Ouyang, Zhong-Hui Wen, Claudio Fiocchi, Wei-Ping Liu, Dai-Yun Chen, Feng-Yuan Li. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitisWorld Journal of Gastroenterology 2005; 11(12): 1775-1778 doi: 10.3748/wjg.v11.i12.1775
Gang Xu, Ke-Li Tian, Guo-Ping Liu, Xue-Jun Zhong, Shao-Ling Tang, Yan-Ping Sun. Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitisWorld Journal of Gastroenterology 2002; 8(3): 575-576 doi: 10.3748/wjg.v8.i3.575
Nilesh Chande, John K. MacDonald, Josh J. Wang, John W.D. McDonald. Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trialsInflammatory Bowel Diseases 2011; 17(9): 1979 doi: 10.1002/ibd.21776
Yvette Meissner, Nathalie Ubrich, Fatima El Ghazouani, Philippe Maincent, Alf Lamprecht. Low molecular weight heparin loaded pH-sensitive microparticlesInternational Journal of Pharmaceutics 2007; 335(1-2): 147 doi: 10.1016/j.ijpharm.2006.11.014
Naamah L. Zitomersky, Menno Verhave, Cameron C. Trenor. Thrombosis and inflammatory bowel disease: A call for improved awareness and preventionInflammatory Bowel Diseases 2011; 17(1): 458 doi: 10.1002/ibd.21334
Qi Ying Lean, Nuri Gueven, Rajaraman D Eri, Rajesh Bhatia, Sukhwinder Singh Sohal, Niall Stewart, Gregory M Peterson, Rahul P Patel. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomesExpert Review of Clinical Pharmacology 2015; 8(6): 795 doi: 10.1586/17512433.2015.1082425
Marija Veljača. Pharmacotherapy of Gastrointestinal Inflammation2004; : 17 doi: 10.1007/978-3-0348-7930-9_2
Nilesh Chande, John WD McDonald, John K MacDonald, Josh J Wang, Nilesh Chande. Cochrane Database of Systematic Reviews2010;  doi: 10.1002/14651858.CD006774.pub3
Junyong Luo, Jichao Cao, Xueliang Jiang, Huifei Cui. Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in miceBiomedicine & Pharmacotherapy 2010; 64(7): 441 doi: 10.1016/j.biopha.2010.01.013